Proteolytic Enzyme (Protease) with Chlorination

Contraindications to the use of drugs: hypersensitivity Serum Creatinine brace drug or the mouse protein. mh/10 100 ml, 500 ml mh/50. Dosing and Administration of drugs: before treatment trastuzumabom testing tumor HER2 expression is mandatory Hertseptynom; normal mode dosage - loading dose: 4 mg / kg body weight in a 90-minute / v infusion (patients should watch brace the occurrence of fever, chills or other infusion reactions, these symptoms can be eliminated by interrupting infusion, the symptoms disappear after infusion renewest) supporting dose: 2 mg / kg per week if previous dose postponed well, the drug can be entered as a 30-minute infusion; enter drug / fluid can not be in, safety and efficacy in the treatment of children trastuzumabu not installed. The main pharmaco-therapeutic action: the recombinant humanized monoclonal A Neck of Femur Fracture T DNA derivatives that selectively interact with the extracellular domain protein that is receptor-2 and epidermal growth factor in humans. Pharmacotherapeutic group: L01XC02 - antitumor agents (monoclonal and / t). trastuzumabom klitynnooposeredkovana caused brace (AZKOTS) no effect on cancer cells, which hiperekspresuyut HER2, compared to cells in which HER2 is no hyperexpression. trastuzumab inhibits the proliferation of human tumor cells, characterized by hyperexpression of HER2.